EV/EBITDA
-2.30
+0.02+0.86%
Sat, 22 Feb 2025 00:57:28 GMT
Summary
- As of February 24, 2025, NTLA EV/EBITDA is -2.30, with a rise of +0.02 (+0.86%) during the most recent trading day.
- Over the past year, NTLA EV/EBITDA has increased by +2.58 (+52.87%).
- NTLA EV/EBITDA is now -30.68% below its all-time high of -1.76.
Performance
NTLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NTLA EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +0.9% | -0.8% | -0.8% |
1 m1 month | -21.7% | +22.0% | +21.6% |
3 m3 months | +13.5% | -13.6% | -13.4% |
6 m6 months | +50.5% | -49.2% | -49.1% |
ytdytd | -4.1% | +3.9% | +3.9% |
1 y1 year | +52.9% | -50.9% | -55.0% |
5 y5 years | +63.7% | +90.4% | -9.6% |
NTLA EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -30.7% | -2.33 | +1.3% | |
3 m | 3-month | -1.76 | -30.7% | -3.01 | +23.6% |
6 m | 6-month | -1.76 | -30.7% | -4.65 | +50.5% |
1 y | 1-year | -1.76 | -30.7% | -6.05 | +62.0% |
3 y | 3-year | -1.76 | -30.7% | -28.10 | +91.8% |
5 y | 5-year | -1.76 | -30.7% | -72.04 | +96.8% |
alltime | all time | -1.76 | -30.7% | -72.04 | +96.8% |
Intellia Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -2.30(+4.1%) |
2024 | -2.21(-59.2%) |
2023 | -5.42(-7.7%) |
2022 | -5.87(-82.5%) |
2021 | -33.56(+25.6%) |
Date | Value |
---|---|
2020 | -26.73(+286.3%) |
2019 | -6.92(+11.6%) |
2018 | -6.20(-12.9%) |
2017 | -7.12(+11.1%) |
2016 | -6.41 |
FAQ
- What is Intellia Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Intellia Therapeutics?
- What is NTLA EV/EBITDA year-to-date change?
- What is Intellia Therapeutics EV/EBITDA year-on-year change?
What is Intellia Therapeutics EV/EBITDA?
The current EV/EBITDA of NTLA is -2.30
What is the all time high EV/EBITDA for Intellia Therapeutics?
Intellia Therapeutics all-time high EV/EBITDA is -1.76
What is NTLA EV/EBITDA year-to-date change?
Intellia Therapeutics EV/EBITDA has changed by -0.09 (-4.07%) since the beginning of the year
What is Intellia Therapeutics EV/EBITDA year-on-year change?
Over the past year, NTLA EV/EBITDA has changed by +2.58 (+52.87%)